Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ludwig Oxford at NCRI Cancer Conference 2019

4 November 2019

Xin Lu and Chunxiao Song present at the National Cancer Research Institute’s annual event

The UK’s largest Cancer Conference ran this year from 3-5^th November in Glasgow. Ludwig Oxford Branch Director Prof. Xin Lu chaired a session on “Emerging technologies for the study of cancer biology”. This session covered recent advances in the areas of Nanopore sequencing technology and the generation of advanced ex vivo 3D models by Prof Hagan Bayley (Department of Chemistry, Oxford), and nanotechnology for biosensing and drug delivery by Prof. Molly Stevens (Imperial College, London). Ludwig Oxford’s Chunxiao Song presented his novel TAPS technology for DNA methylation detection. This innovative method is now being tested for the measurement of epigenetic signatures within liquid biopsy samples from cancer patients with the aim of earlier cancer detection.